PacBio's HiFi Sequencing Technology Chosen for Singapore's Largest Long-Read Sequencing Project

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PR...

August 06, 2024 | Tuesday | News
NurExone Biologic Inc Achieves GMP-Grade Manufacturing for ExoPTEN Nanodrug’s siRNA Sequence

NurExone Biologic Inc, a pioneering biopharmaceutical company, is thrilled to announce an important milestone in its regenerative medicine efforts. The C...

August 02, 2024 | Friday | News
AbCellera Expands Collaboration with Eli Lilly to Develop Therapeutic Antibodies Across Multiple Therapeutic Areas

AbCellera (Nasdaq: ABCL) announcedthat it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies f...

August 01, 2024 | Thursday | News
Novo Holdings Invests £50M in Oxford Nanopore Technologies, Pioneers of Advanced DNA/RNA Sequencing

Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing &pou...

August 01, 2024 | Thursday | News
Biogen, Beckman Coulter, and Fujirebio Announce Collaboration to Develop Blood Biomarkers for Alzheimer's Disease

The collaboration aims to identify and develop accessible and mini-invasive blood biomarkers specific to tau pathology in the brain These tools ...

July 31, 2024 | Wednesday | News
IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
Nexcella Secures $8 Million CIRM Grant to Advance CAR-T Therapy for AL Amyloidosis

Nexcella, Inc.  a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced tha...

July 26, 2024 | Friday | News
Oxford Nanopore and Plasmidsaurus Announce Multi-Year Partnership to Transform Plasmid Sequencing

Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based com...

July 25, 2024 | Thursday | News
GeneCentric Therapeutics Secures AMA PLA Code for AI-Driven PurIST Pancreatic Cancer Test

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that the American Medical Assoc...

July 25, 2024 | Thursday | News
GC Cell and Lukas Biomedical Forge Strategic International Partnership

 GC Cell Corporation (hereinafter referred to as "GC Cell"; 144510:KOSDAQ) and Lukas Biomedical Co., Ltd. (hereinafter referred to as "Lukas," TWSE ...

July 22, 2024 | Monday | News
Innovent Biologics Announces Phase 3 Success for Mazdutide in Treating Type 2 Diabetes

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of on...

July 22, 2024 | Monday | News
Merck Invests €6.6 Million to Expand Cell Culture Media Production at Nantong Site

€ 6.6 million investment at Nantong site expands production capabilities for cell culture media  Supports local biopharma manufact...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Thermo Fisher Scientific Finalizes $3.1 Billion Acquisition of Olink, Ushering in a New Era in Proteomics

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, has announced the successful completion of ...

July 11, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close